Streetbeat News

Stock Prices

MINM

Shares of Minim (MINM) were halted due to a circuit breaker after surging 16.3% to the upside. Circuit breakers are designed to prevent stocks from crashing by temporarily halting trading after a stock experiences significant price movements in a short period.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 5:06 pm

SPOT

Spotify Technology SA (NYSE:SPOT) saw its stock rise by over 10% following the announcement of a 17% workforce reduction. The stock's positive performance, with a 20% increase over the past month and over 120% year-to-date, is attributed to investor optimism for a leaner, more efficient company. Technical analysis suggests the rally may continue, as indicated by a Golden Cross pattern on the stock's chart, where the 50-day SMA crossed over the 100-day SMA, historically signaling an uptrend.

Portfolio Pulse from Surbhi Jain

December 04, 2023 | 5:05 pm

GOOGL

NFLX

QQQ

David Keller, CMT, outlines four potential scenarios for the Nasdaq 100, represented by the QQQ ETF, following a divergence in performance between the S&P 500 and Nasdaq 100, with the latter showing signs of potential pullback due to overbought conditions in growth stocks like NFLX and GOOGL. The scenarios range from very bullish to super bearish, with probabilities assigned to each. Keller's base case is a mildly bullish scenario with a 60% probability, suggesting a pullback followed by a rally. The article is for educational purposes and does not constitute financial advice.

Portfolio Pulse from David Keller

December 04, 2023 | 5:05 pm

CELH

Stifel has maintained its Buy rating on Celsius Holdings (NASDAQ:CELH) but reduced its price target from $191.00 to $64.00. Despite the lowered target, the new price suggests a potential 18.65% upside from the current price of $53.94. Celsius Holdings, with a focus on the energy drink market in North America, has a 20-year distribution agreement with PepsiCo, which owns an 8.5% stake in the company.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 5:00 pm

ESTC

Goldman Sachs has maintained a Neutral rating for Elastic (NYSE:ESTC) but raised its price target from $83.00 to $93.00. Despite this, Elastic's shares are trading down 0.9% at $109.21, and the new price target suggests a potential decline of 14.84% from the current price. Elastic is a software company that specializes in enterprise search, observability, and security.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 5:00 pm

ZTS

Over the past 5 years, Zoetis (NYSE:ZTS) has produced an average annual return of 15.54%, outperforming the market by 3.99% on an annualized basis. A $100 investment in ZTS 5 years ago would be worth $200.59 today. Zoetis currently has a market cap of $83.26 billion. The article highlights the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 5:00 pm

CBRL

Piper Sandler has maintained a Neutral rating on Cracker Barrel Old (NASDAQ:CBRL) but lowered its price target from $96.00 to $75.00. Cracker Barrel's stock is currently trading at $72.00, down 0.5% over the last 24 hours. The new price target suggests a potential upside of 4.17%. Cracker Barrel operates full-service restaurants in the U.S., with a significant portion of revenue coming from its gift shops. Analyst ratings are provided by financial experts and are subject to error.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 5:00 pm

ANET

Arista Networks (NYSE:ANET) has significantly outperformed the market, with an average annual return of 30.44% over the past 5 years. A $1000 investment in ANET 5 years ago would be worth $3,564.74 today. Arista Networks currently has a market cap of $66.11 billion.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 5:00 pm

MRSN

Citigroup has upgraded Mersana Therapeutics (NASDAQ:MRSN) to a Buy rating with a new price target of $5.00, up from the previous target of $1.00. Mersana's shares have risen 5.26% to $2.00 in the last 24 hours. The new price target suggests a potential upside of 150.0% from the current share price. Mersana is a clinical-stage biopharmaceutical company focused on developing targeted drugs with its proprietary ADC platforms.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 5:00 pm

KRRO

Korro Bio's stock price has increased following a positive initiation of coverage by HC Wainwright & Co., who gave it a Buy rating and set a price target of $100.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 4:55 pm